演讲嘉宾
演讲主题 PRESENTATION TOPIC
Accelerated Next-Generation Cell Line Development for anti-COVID-19 Neutralizing mAbs
蔡洁行
高级副总裁
药明生物
Jill Cai
SVP
WuXi Biologics
Ms Jill Cai, SVP of Cell and Protein Sciences at WuXi Biologics, responsible for protein generation, cell line development and GMP cell banking. She has managed many CMC projects as well, including recent rapid CMC development of anti-COVID 19 mAbs.